Non-tuberculous Mycobacteria — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Multi-drug regimen including IV Amikacin, IV Tigecycline or Imipenem, and oral macrolide
M. abscessus is one of the most treatment-resistant NTM species. The treatment regimen is complex and prolonged: an induction phase typically includes IV Amikacin, IV Tigecycline (or Imipenem/Cefoxitin), and an oral macrolide (Azithromycin or Clarithromycin), with transition to oral agents for a continuation phase. Macrolide susceptibility (erm gene status) must be checked as inducible macrolide resistance is common in M. abscessus subsp. abscessus. Total treatment duration is typically 12+ months of culture-negative sputum. Standard TB drugs are ineffective.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/infections